Venture&Growth Archives - Gilde Healthcare

team
Venture&Growth

The Venture&Growth fund is managed by a dedicated investment team and is focused on:

  • healthtech and therapeutics
  • early revenue stage or clinical stage
  • equity investments of up to €50 million per portfolio company
  • Europe and North America
  • significant minority ownership

See Venture&Growth Portfolio for an overview of the portfolio.

The Venture&Growth fund is managed by a dedicated investment team and is focused on:

  • healthtech and therapeutics
  • early revenue stage or clinical stage
  • equity investments of up to €50 million per portfolio company
  • Europe and North America
  • significant minority ownership

See Venture&Growth Portfolio for an overview of the portfolio.

Ariane de Marcillac

Associate HealthTech
Venture&Growth
Ariane joined Gilde Healthcare in 2024. She works as part of the HealthTech investment team and is involved in deal sourcing, due diligence, and portfolio management. Prior to joining Gilde, Ariane was a Venture Capital...

Arthur Franken

General Partner Healthtech/Therapeutics
Venture&Growth
Arthur joined Gilde Healthcare in 2001 and was part of the team that started the Venture&Growth strategy. He oversees investments across our Venture&Growth fund in sectors such as biopharmaceuticals, medtech, diagnostics, and digital health. Previously,...

Chris Allen

Associate HealthTech
Venture&Growth
Chris joined Gilde Healthcare in 2023 focusing on HealthTech investments. Prior to joining Gilde Chris worked as a medical doctor, training at St Mary's, London. Upon completion of training alongside clinical work, he led the...

Edward Hanlon

Investment Manager Healthtech
Venture&Growth
Edward joined Gilde Healthcare in 2020. He supports the firm on deal origination, assessment, and portfolio management, with a focus on healthtech investments. Prior to Gilde, Edward worked in healthcare advisory for Health Advances, gaining...

Edwin de Graaf

Managing Partner
Edwin is a Managing Partner and Co-Founder of Gilde Healthcare. He is jointly responsible for all fund management and investment activities in Gilde’s Venture&Growth fund. Before his role at Gilde, Edwin spent three years as...

Geoff Pardo

General Partner Healthtech
Venture&Growth
Geoff joined Gilde Healthcare in 2011. He oversees investments across the Venture&Growth fund in North America. Before joining the firm, Geoff gained experience leading investments during his time as Partner at Spray Venture Partners, and...

Henry Zubaida

Investment Manager Healthtech
Venture&Growth
Henry joined Gilde Healthcare in 2018 and serves as Investment Manager with a focus on the healthtech sector. He previously worked in business development for Biolinq, a US-based start-up, developing a novel generation of continuous...

Iskander Shadid

Analyst Therapeutics
Venture&Growth
Iskander Shadid joined Gilde in 2024 as part of the Therapeutics investment team. He is involved in deal sourcing, due diligence and portfolio management. Prior to Gilde, Iskander worked as a PhD researcher at Harvard...

Janke Dittmer

General Partner Healthtech
Venture&Growth
Janke joined Gilde Healthcare in 2011 as a Partner. He is responsible for Gilde’s European healthtech investments in key sectors including medtech, digital health, diagnostics, and life science tools. Prior to joining Gilde, Janke was...

Joep Muijrers

General Partner Public Investments
Venture&Growth
Joep joined Gilde Healthcare in 2021. He focuses on investing in late-stage opportunities including publicly traded companies that deliver better care at lower cost. He is actively engaged in multi-stakeholder interaction and is responsible for...

Karthik Bolisetty

Investment Manager Healthtech
Venture&Growth
Karthik joined Gilde Healthcare in 2023. He supports the Venture&Growth team in deal origination, assessment of investment case, and portfolio management in Gilde’s healthtech investments. Karthik was previously part of the investment team at Northpond...

Marion Pouillard

Senior Associate Therapeutics
Venture&Growth
Marion joined Gilde Healthcare in 2023. She works across both the firm’s private and publicly listed investments, and is involved in deal sourcing, due diligence and portfolio management. She previously worked as an associate at...

Nellie Ingram

Executive Assistant
Support office
Nellie joined Gilde Healthcare in 2022. She supports the company with day-to-day administrative and organisational duties, including scheduling and calendar management. Nellie previously worked as Office Manager for four years at Longfellow Real Estate Partners,...

Pieter van der Meer

Managing Partner
Pieter is Founder and Managing Partner of Gilde Healthcare and leads the Venture&Growth and Private Equity strategies. He is responsible for general business management and corporate development, overseeing the investment committees and fundraising. Pieter joined...

Pommeline Korstanje

Associate Public Investments
Venture&Growth
Pommeline joined Gilde Healthcare in 2024. She supports the Venture&Growth team with deal sourcing, due diligence, and portfolio management, with a focus on its healthtech investments. Before her time at Gilde, Pommeline worked as Clinical...

Rich Wilmot

Partner HealthTech
Venture&Growth
Rich joined Gilde Healthcare as Partner in 2023. He oversees deal origination, investment processes and portfolio management for healthtech investments in Gilde’s Venture&Growth fund. He previously served for seven years as the Global Head of...

Sonia Hallen

Investment Manager Therapeutics
Venture&Growth
Sonia joined Gilde Healthcare in 2024. She oversees investments by Gilde’s Growth&Venture fund, with a focus on the therapeutic and healthtech sectors. Sonia was previously Vice President at EQT Life Sciences and was responsible for...

Stefan Luzi

Partner Therapeutics
Venture&Growth
Stefan joined Gilde Healthcare in 2015. As Partner in our Venture&Growth team, he focuses on capital investments in the biopharmaceutical and therapeutics sectors. Before joining Gilde, Stefan worked at Merck KGaA where he completed international...

Susana Amorim

Investment Manager Healthtech
Venture&Growth
Susana joined Gilde Healthcare in 2021. As Investment Manager for Gilde’s Venture & Growth team, Susana focuses on the healthtech sector, handling deal sourcing, investment diligence, and portfolio management. Before joining Gilde, she was a...

Tristan Maguet

Senior Associate Therapeutics
Venture&Growth
Tristan joined Gilde Healthcare in 2022. He focuses on the therapeutics sector and is primarily involved in deal sourcing, due diligence, and portfolio management. Before joining Gilde, Tristan was an Investment Analyst at Aescap, specializing...

Zosia van Eesteren

Associate Therapeutics
Venture&Growth
Zosia joined Gilde Healthcare in 2022. She focuses on the therapeutics sector and is responsible for analyzing both private and publicly traded companies. She manages the identification, assessment, and preparation of investment opportunities. She gained...

Professor Dr. Rene Bernards

Operational Partner
Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...

Mika Nishimura

Operational Partner
Mika is a commercialization executive with extensive leadership experience in conceiving, planning, and launching disruptive medical technologies in 50 markets across North America, EMEA, Asia-Pacific, and Latin America.  She has an exceptional track record of...

Dr. Paul Parren

Operational Partner
Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved...

Michael R. Jaff, DO

Operational Partner
Michael R. Jaff, DO is the Chief Medical Officer and Vice-President of clinical affairs, technology and innovation at Boston Scientific Corporation. A professor of medicine at Harvard Medical School, Dr. Jaff was the President of...

David Nicholson

Operational Partner
David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a...